The Oracle Paradox: Why Wall Street Still Says 'Buy' as the Stock Crashes

Oracle has plunged 56% from its September 2025 highs, yet analysts maintain a 'Strong Buy' rating with 66.7% upside targets.

Oracle is in the midst of a stunning collapse. The $434.5 billion mega-cap, one of the biggest names in enterprise software and cloud computing, has been cut down by more than half from its September 2025 peak. Yet Wall Street analysts still call it a "Strong Buy." This disconnect between the market's verdict and professional sentiment reveals something genuinely strange happening with one of tech's largest names. You can watch the full breakdown here or listen to the podcast version.

The Numbers That Should Stop You

Let's establish the scale of Oracle's decline. The stock is trading 56.4% below its 52-week high of $345.72, set on September 10, 2025. Over the past three months alone, ORCL has dropped 26%. That's the brutal part — while this was happening, the S&P 500 actually rallied 2%. This isn't Oracle getting caught in a market-wide downturn. This is Oracle bleeding out while everything else climbs.

Zoom out further and the picture worsens. Over 52 weeks, Oracle is down 37.2%. Year-to-date, down 22.6%. The S&P 500, by contrast, rose 18.6% over that same 52-week period and gained 12.7% year-to-date. The gap isn't small — Oracle is moving in the opposite direction of the market. Technically, the stock has been trading below its 200-day moving average since mid-June, a sign of sustained weakness, though it has recently climbed back above its 50-day moving average.

The Debt Trap

The culprit, according to investors, is one word: spending. Specifically, Oracle's massive bet on AI infrastructure is giving Wall Street serious pause.

Here's where the numbers get staggering. Oracle raised $43 billion in debt in fiscal year 2026 to fund its AI ambitions. It's not done. The company expects to raise roughly $40 billion more in fiscal year 2027, including a planned $20 billion equity issuance. All of it flows toward one target: financing the data-center buildout that Oracle believes will power its AI future.

The problem is what this does to Oracle's balance sheet. More debt means higher leverage. An equity issuance means dilution — your slice of the pie gets smaller. Add in concerns about weaker free cash flow ahead, and you've got exactly the recipe to spook investors. A company borrowing tens of billions, selling new stock, and squeezing cash flow simultaneously is not a formula that builds confidence.

The Paradox

Then comes the twist that makes this story genuinely odd. Despite the 56% drop, Wall Street has not abandoned Oracle. Among 44 analysts covering the stock, the consensus is "Strong Buy." Their mean price target sits at $251.50 — which implies 66.7% upside from current levels. Analysts are collectively saying this beaten-down stock could nearly double from here.

Compare this to Palantir, another company in the AI infrastructure conversation. Palantir has gained 17.8% over the past year and 4.8% year-to-date — both outperforming Oracle by a wide margin. The market is rewarding Palantir while punishing Oracle, even though both are betting on similar AI futures. That raises an uncomfortable question: is this really about AI spending being bad, or is it specifically about Oracle's spending strategy worrying investors?

The Real Question

Oracle sits at a crossroads. Is this a mega-cap giant temporarily punished for playing the long game on AI infrastructure, primed for a rebound when the payoff arrives? Or is the market catching something analysts are missing — a debt-fueled bet that won't deliver the returns Oracle needs? That question will define the stock over the next few quarters.